AstraZeneca PLC ADRhedged (AMEX: AZNH) Stock Competitors & Peer Comparison

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, RPRX has a market cap of 25.6B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while RPRX trades at $57.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas RPRX's P/E ratio is 11.01. In terms of profitability, AZNH's ROE is +0.00%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, AZNH is less volatile compared to RPRX. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check RPRX's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, CORT has a market cap of 12.8B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CORT trades at $121.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas CORT's P/E ratio is 338.69. In terms of profitability, AZNH's ROE is +0.00%, compared to CORT's ROE of +0.08%. Regarding short-term risk, AZNH is less volatile compared to CORT. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check CORT's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while WBA trades at $11.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas WBA's P/E ratio is -1.64. In terms of profitability, AZNH's ROE is +0.00%, compared to WBA's ROE of -0.57%. Regarding short-term risk, AZNH is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check WBA's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, KNSA has a market cap of 6B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while KNSA trades at $79.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas KNSA's P/E ratio is 81.69. In terms of profitability, AZNH's ROE is +0.00%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, AZNH is less volatile compared to KNSA. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check KNSA's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, LQDA has a market cap of 2.5B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while LQDA trades at $27.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas LQDA's P/E ratio is 20.20. In terms of profitability, AZNH's ROE is +0.00%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, AZNH is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check LQDA's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, PBH has a market cap of 2.3B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while PBH trades at $49.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas PBH's P/E ratio is 11.09. In terms of profitability, AZNH's ROE is +0.00%, compared to PBH's ROE of +0.09%. Regarding short-term risk, AZNH is less volatile compared to PBH. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check PBH's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while HROWL trades at $25.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas HROWL's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, AZNH is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check HROWL's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while HROWM trades at $26.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas HROWM's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, AZNH is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check HROWM's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, LTGO has a market cap of 963.7M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while LTGO trades at $16.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas LTGO's P/E ratio is -6.36. In terms of profitability, AZNH's ROE is +0.00%, compared to LTGO's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check LTGO's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, HELP has a market cap of 683.7M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while HELP trades at $11.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas HELP's P/E ratio is -2.65. In terms of profitability, AZNH's ROE is +0.00%, compared to HELP's ROE of -0.71%. Regarding short-term risk, AZNH is less volatile compared to HELP. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check HELP's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while SVA trades at $6.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas SVA's P/E ratio is -5.68. In terms of profitability, AZNH's ROE is +0.00%, compared to SVA's ROE of -0.01%. Regarding short-term risk, AZNH is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check SVA's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, CUVL has a market cap of 281.4M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CUVL trades at $5.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas CUVL's P/E ratio is 12.04. In terms of profitability, AZNH's ROE is +0.00%, compared to CUVL's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to CUVL. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check CUVL's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, HITI has a market cap of 226.7M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while HITI trades at $2.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas HITI's P/E ratio is -9.53. In terms of profitability, AZNH's ROE is +0.00%, compared to HITI's ROE of -0.36%. Regarding short-term risk, AZNH is less volatile compared to HITI. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check HITI's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, CELG-RI has a market cap of 224.7M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CELG-RI trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to CELG-RI's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to CELG-RI. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check CELG-RI's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, ETRA has a market cap of 197.7M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while ETRA trades at $9.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas ETRA's P/E ratio is -3.52. In terms of profitability, AZNH's ROE is +0.00%, compared to ETRA's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to ETRA. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check ETRA's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, TRXB has a market cap of 116.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while TRXB trades at $14.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas TRXB's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to TRXB's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to TRXB. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check TRXB's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, CTOR has a market cap of 78.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CTOR trades at $0.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas CTOR's P/E ratio is -1.81. In terms of profitability, AZNH's ROE is +0.00%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, AZNH is less volatile compared to CTOR. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check CTOR's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, ATLN has a market cap of 68.6M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while ATLN trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas ATLN's P/E ratio is -0.68. In terms of profitability, AZNH's ROE is +0.00%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, AZNH is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check ATLN's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, RTSN has a market cap of 43.7M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while RTSN trades at $11.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas RTSN's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to RTSN's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to RTSN. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check RTSN's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while RAD trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas RAD's P/E ratio is -0.05. In terms of profitability, AZNH's ROE is +0.00%, compared to RAD's ROE of +2.76%. Regarding short-term risk, AZNH is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check RAD's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while GLTO trades at $21.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas GLTO's P/E ratio is -1.78. In terms of profitability, AZNH's ROE is +0.00%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, AZNH is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check GLTO's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, NSRX has a market cap of 28.6M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while NSRX trades at $3.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas NSRX's P/E ratio is -4.61. In terms of profitability, AZNH's ROE is +0.00%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, AZNH is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check NSRX's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, SCYX has a market cap of 25.3M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while SCYX trades at $4.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas SCYX's P/E ratio is -1.18. In terms of profitability, AZNH's ROE is +0.00%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, AZNH is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check SCYX's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, COSM has a market cap of 17.1M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while COSM trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas COSM's P/E ratio is -0.43. In terms of profitability, AZNH's ROE is +0.00%, compared to COSM's ROE of -1.19%. Regarding short-term risk, AZNH is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check COSM's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, CNSY has a market cap of 12.3M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CNSY trades at $1.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas CNSY's P/E ratio is -0.43. In terms of profitability, AZNH's ROE is +0.00%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, AZNH is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check CNSY's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, BFRI has a market cap of 11.8M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while BFRI trades at $0.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas BFRI's P/E ratio is -1.68. In terms of profitability, AZNH's ROE is +0.00%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, AZNH is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check BFRI's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CJJD trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas CJJD's P/E ratio is -0.46. In terms of profitability, AZNH's ROE is +0.00%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, AZNH is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check CJJD's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while SSY trades at $1.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas SSY's P/E ratio is -2.86. In terms of profitability, AZNH's ROE is +0.00%, compared to SSY's ROE of -0.09%. Regarding short-term risk, AZNH is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check SSY's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while SCNX trades at $3.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas SCNX's P/E ratio is -1.86. In terms of profitability, AZNH's ROE is +0.00%, compared to SCNX's ROE of -0.54%. Regarding short-term risk, AZNH is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check SCNX's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, BGMS has a market cap of 5.4M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while BGMS trades at $0.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas BGMS's P/E ratio is -0.28. In terms of profitability, AZNH's ROE is +0.00%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, AZNH is less volatile compared to BGMS. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check BGMS's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, POM has a market cap of 4.2M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while POM trades at $0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas POM's P/E ratio is -0.11. In terms of profitability, AZNH's ROE is +0.00%, compared to POM's ROE of +0.16%. Regarding short-term risk, AZNH is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check POM's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, EOCN has a market cap of 3.4M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while EOCN trades at $3.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas EOCN's P/E ratio is -0.23. In terms of profitability, AZNH's ROE is +0.00%, compared to EOCN's ROE of N/A. Regarding short-term risk, AZNH is less volatile compared to EOCN. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check EOCN's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, BFRIW has a market cap of 3.2M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while BFRIW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas BFRIW's P/E ratio is -0.01. In terms of profitability, AZNH's ROE is +0.00%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, AZNH is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check BFRIW's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, PAVS has a market cap of 3M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while PAVS trades at $3.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas PAVS's P/E ratio is -0.04. In terms of profitability, AZNH's ROE is +0.00%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, AZNH is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check PAVS's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while MDVL trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas MDVL's P/E ratio is -0.05. In terms of profitability, AZNH's ROE is +0.00%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, AZNH is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check MDVL's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while ATNFW trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas ATNFW's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, AZNH is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check ATNFW's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while BGMSP trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, AZNH's ROE is +0.00%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, AZNH is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check BGMSP's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while LFLYW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, AZNH's ROE is +0.00%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, AZNH is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check LFLYW's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, PRPH has a market cap of 126.1K. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while PRPH trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas PRPH's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, AZNH is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check PRPH's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, POZN has a market cap of 0. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while POZN trades at $5.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas POZN's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to POZN's ROE of +0.61%. Regarding short-term risk, AZNH is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check POZN's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, CPD has a market cap of 0. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while CPD trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas CPD's P/E ratio is N/A. In terms of profitability, AZNH's ROE is +0.00%, compared to CPD's ROE of N/A. Regarding short-term risk, AZNH is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check CPD's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while ESRX trades at $92.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas ESRX's P/E ratio is 10.69. In terms of profitability, AZNH's ROE is +0.00%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, AZNH is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check ESRX's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while IPXL trades at $18.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas IPXL's P/E ratio is -10.11. In terms of profitability, AZNH's ROE is +0.00%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, AZNH is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check IPXL's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while SHPG trades at $179.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas SHPG's P/E ratio is 11.35. In terms of profitability, AZNH's ROE is +0.00%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, AZNH is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for AZNH.Check SHPG's competition here

AstraZeneca PLC ADRhedged (AMEX: AZNH) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AZNH stands at 1.6M. In comparison, OREX has a market cap of 0. Regarding current trading prices, AZNH is priced at $53.74 on the AMEX, while OREX trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AZNH currently has a P/E ratio of 38.35, whereas OREX's P/E ratio is -0.14. In terms of profitability, AZNH's ROE is +0.00%, compared to OREX's ROE of -0.54%. Regarding short-term risk, AZNH is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for AZNH.Check OREX's competition here